Showing 65,641 - 65,660 results of 105,799 for search '(( 10 we decrease ) OR ( 5 ((wt decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.22s Refine Results
  1. 65641

    Table_8_Integrated Analysis of the Transcriptome and Metabolome Revealed the Molecular Mechanisms Underlying the Enhanced Salt Tolerance of Rice Due to the Application of Exogenous... by Ziyan Xie (9927878)

    Published 2021
    “…A comparative transcriptome analysis revealed that complex molecular pathways contribute to melatonin-mediated salt tolerance. …”
  2. 65642

    Table_3_Integrated Analysis of the Transcriptome and Metabolome Revealed the Molecular Mechanisms Underlying the Enhanced Salt Tolerance of Rice Due to the Application of Exogenous... by Ziyan Xie (9927878)

    Published 2021
    “…A comparative transcriptome analysis revealed that complex molecular pathways contribute to melatonin-mediated salt tolerance. …”
  3. 65643

    Image_2_Bacteria Community Inhabiting Heterobasidion Fruiting Body and Associated Wood of Different Decay Classes.tif by Wenzi Ren (12491701)

    Published 2022
    “…Out of 7,462 operational taxonomic units (OTUs), about 5,918 OTUs were obtained from the fruiting body and 5,469 OTUs were obtained from the associated dead wood. …”
  4. 65644

    Table_2_Integrated Analysis of the Transcriptome and Metabolome Revealed the Molecular Mechanisms Underlying the Enhanced Salt Tolerance of Rice Due to the Application of Exogenous... by Ziyan Xie (9927878)

    Published 2021
    “…A comparative transcriptome analysis revealed that complex molecular pathways contribute to melatonin-mediated salt tolerance. …”
  5. 65645
  6. 65646
  7. 65647
  8. 65648
  9. 65649
  10. 65650
  11. 65651
  12. 65652
  13. 65653
  14. 65654
  15. 65655
  16. 65656
  17. 65657
  18. 65658
  19. 65659
  20. 65660

    Data_Sheet_1_Early Changes in B and Plasma Cell Subsets and Traditional Serological Markers as Predictors of SRI-4 Response to Therapy in Systemic Lupus Erythematosus.docx by Ioannis Parodis (2851211)

    Published 2022
    “…</p>Results<p>In the analysis of the entire cohort, SRI-4 responders showed more prominent decreases from baseline through week 52 in CD19<sup>+</sup>CD20<sup>+</sup>CD27<sup>–</sup> naïve B cells (median change: −61.2% versus −50.0%; P = 0.004), CD19<sup>+</sup>CD20<sup>–</sup>CD27<sup>bright</sup> plasmablasts (−44.9% versus −33.3%; P = 0.011), and CD19<sup>+</sup>CD20<sup>–</sup>CD138<sup>+</sup> long-lived plasma cells (−48.2% versus −37.1%; P = 0.024), and a more prominent rapid (+92.0% versus +66.7%; P = 0.002) and early (+60.0% versus +49.5%; P = 0.033) expansion of CD19<sup>+</sup>CD20<sup>+</sup>CD27<sup>+</sup> memory B cells than non-responders. …”